A nasal spray that may fend off coronavirus has been formulated by researchers at the University of California, San Francisco, according to a report. The aerosol spray, called AeroNabs, is an antiviral aimed at preventing COVID-19, though it is not a cure, the researchers stated in a release. The researchers explained that the SARS-CoV-2 relies on spike proteins to infect human cells. The authors explained in the report that they developed “single-domain antibodies (nanobodies) that potently disrupt the interaction between the SARS-CoV-2 Spike and ACE2." These mean it could be practical to administer via a shelf-stable inhaler or nasal spray.

Source: Fox News August 12, 2020 18:00 UTC